Listed by the USPTO as SHOSTAK, ANDREY
Tech Center 3700 • Art Units: 2426 3735 3791 3794
This examiner grants 53% of resolved cases
SHOSTAK, ANDREY is assigned to Tech Center 3700 and Art Unit 2426. Across 432 resolved cases, the profile shows a 53.0% allowance rate and a median of 1292 days to allowance. The record supports a meaningful assessment of outcomes, while the timing figure reflects a prolonged path to allowance.
The interview lift is 62.4%, indicating a substantial allowance association for interviews. The listed companies are DexCom Inc., Omron Corporation, and The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. The listed firms are LEVINE BAGADE HAN LLP, PATTERSON + SHERIDAN, L.L.P. - Dexcom, and SMART & BIGGAR LP. Practitioners may give interviews a prominent place in prosecution planning, supported by focused amendments and arguments.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19002227 | SYSTEM AND METHOD FOR DETERMINING IMPACT ON BODY PART AND RECOMMENDING EXERCISE | Non-Final OA | Samsung Electronics Co., Ltd. |
| 18403694 | APTAMER-BASED ANALYTE MONITORING SYSTEM | Final Rejection | Biolinq Incorporated |
| 19029581 | GLYCEMIC URGENCY ASSESSMENT AND ALERTS INTERFACE | Non-Final OA | Dexcom, Inc. |
| 18538982 | CONTINUOUS GLUCOSE MONITORING SYSTEM INSIGHT NOTIFICATIONS | Final Rejection | Dexcom, Inc. |
| 19058735 | BLOOD PRESSURE MEASURING DEVICE | Non-Final OA | OMRON HEALTHCARE Co., Ltd. |
| 17827498 | SPHYGMOMANOMETER | Non-Final OA | OMRON HEALTHCARE CO., LTD. |
| 17259659 | SYSTEM AND METHOD FOR MONITORING NEURAL SIGNALS | Final Rejection | The General Hospital Corporation |
| 18413578 | GLUCOSE LEVEL CHANGE DETECTION IN EYES USING POLARIZED LIGHT | Non-Final OA | Meta Platforms Technologies, LLC |
| 18780914 | DETECTION DEVICE AND BODY-WORN DEVICE | Final Rejection | CASIO COMPUTER CO., LTD. |
| 17233206 | PHYSIOLOGICAL ACOUSTIC MONITORING SYSTEM | Non-Final OA | MASIMO CORPORATION |
| 19041501 | CARDIAC MONITOR USING GAIT INFORMATION | Non-Final OA | Cardiac Pacemakers, Inc. |
| 18677627 | INDWELLING VASCULAR PROBE FOR BLOOD PARAMETER SENSING | Non-Final OA | Becton, Dickinson and Company |
| 18228347 | ACCESSIBILITY DIAGNOSIS FOR COSMETIC APPLICATOR CONFIGURED FOR USERS WITH LIMITED MOBILITY | Final Rejection | L'OREAL |
| 18407584 | INTRAVASCULAR DEVICES, SYSTEMS, AND METHODS HAVING SEPARATE SECTIONS WITH ENGAGED CORE COMPONENTS | Non-Final OA | PHILIPS IMAGE GUIDED THERAPY CORPORATION |
| 18972757 | BODY ATTACHABLE UNIT FOR CONTINUOUS BLOOD GLUCOSE MEASUREMENT | Non-Final OA | I-SENS, INC. |
| 18407501 | iNPH PREDICTION METHOD BASED ON THE VISUAL ODDBALL PARADIGM | Final Rejection | TIANJIN UNIVERSITY |
| 17775199 | EXHALED BREATH COLLECTION DEVICE | Non-Final OA | Danny O'hare |
| 18301967 | MASK-BASED DIAGNOSTIC UTILIZING AI ALGORITHMS FOR IMPROVED PATIENT OUTCOMES | Non-Final OA | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy53.0% of resolved applications examined by Andrey Shostak were allowed (432 resolved cases), compared with 68.0% across Art Unit 2426 over the last five years.
This examiner's interview lift is +62.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Andrey Shostak took 1,292 days on average from filing to allowance.
Andrey Shostak examines applications in Art Unit 2426 in Tech Center 3700 (Medical Devices & Mechanical Engineering).